The trend of decreasing ROCE and revenue despite increased c...
The trend of decreasing ROCE and revenue despite increased capital deployment is concerning, suggesting the company may be losing its competitive advantage or market share. The stock has remained flat over the last five years, indicating investors are not impressed with these trends.
Jafron BiomedicalLtd (SZSE:300529) Is Reinvesting At Lower Rates Of Return
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment